Press releases
- Press releases
- Browse
Press releases
New CEO brings wealth of industry experience to Kalibrant More
Collaborative agreement enhances access to new technology More
GPRSE increases the number of 'centres' offering its unique scheme More
Kalibrant has patents BG2336327 and GB2336207 issued in the UK More
Kalibrant receives Foresight award from the DTI in recognition of their exciting technology and building on their previous SMART award More
Nanogen announced the initiation of four additional developmental site agreements with Beth Israel Deaconess Medical Center, KnowledGENE.com, Inc., Creighton University School of Medicine, and Copenhagen University Hospitals. More
Nanogen awarded its twentieth U.S. Patent, No. 6,162,603, entitled "Hybridization of Polynucleotides Conjugated with Chromophores and Fluorophores to Generate Donor-To-Donor Energy Transfer System" (the "'603 Patent"). More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2010 - 414 pages - $690
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Jul 2005 - 52 pages - $515
Feb 2009 - 242 pages - $690
Apr 2010 - 5 pages - $500
Apr 2011 - 25 pages - $500
Mar 2011 - 38 pages - $340
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us